Mirtazapine Uses
Mirtazapine is FDA-approved for the treatment of major depressive disorder (MDD) in adults, and it is widely used off-label for insomnia, anxiety disorders, and various other psychiatric and medical conditions. 1
FDA-Approved Indication
The only FDA-approved use of mirtazapine is for major depressive disorder in adults 1. In this capacity, mirtazapine demonstrates comparable efficacy to other second-generation antidepressants (SSRIs, SNRIs), with the notable advantage of a faster onset of action compared to fluoxetine, paroxetine, or sertraline 2.
Off-Label Uses
While the FDA approval is limited to MDD, mirtazapine has extensive off-label applications supported by varying levels of evidence:
Psychiatric Conditions
- Anxiety disorders: Including panic disorder, post-traumatic stress disorder, generalized anxiety disorder, social phobia, and obsessive-compulsive disorder 3, 4
- Dysthymia 3
- Schizophrenia (as add-on therapy) 4
- Insomnia disorder: Recent high-quality evidence from 2025 shows that low-dose mirtazapine (7.5-15 mg/day) provides statistically significant and clinically relevant reduction in insomnia severity at 6 weeks, though this effect was not sustained at later time points 5
Medical Conditions
- Depression with medical comorbidities: Including poststroke depression, HIV-related depression, elderly depression, and depression associated with epilepsy, Alzheimer's disease, cardiovascular disease, and respiratory disease 3, 6
- Cancer-related symptoms: Reduces sadness, nausea, sleep disruption, and pain while improving quality of life 6
- Postoperative nausea and vomiting 7
- Weight loss and appetite stimulation (due to its side effect profile) 7
- Pain syndromes: Including tension-type headaches, fibromyalgia, and cancer pain 3, 6
- Substance use disorders: Alcohol and other substance dependencies 3
Important Clinical Considerations
Unique Pharmacological Profile
Mirtazapine is a noradrenergic and specific serotonergic antidepressant (NaSSA) with a dual mode of action that may explain its rapid onset 8. It enhances norepinephrine and serotonin transmission while blocking 5-HT2 and 5-HT3 receptors 8.
Common Side Effects
The most frequent adverse effects include:
- Somnolence (54% vs 18% placebo) 1
- Increased appetite (17% vs 2% placebo) 1
- Weight gain (12% vs 2% placebo) 1
- Dry mouth (25% vs 15% placebo) 1
Critical caveat: Unlike SSRIs, mirtazapine does not cause sexual dysfunction 8, making it advantageous when sexual side effects are a concern.
Dosing Considerations
- Age and sex differences: Women exhibit 18% higher concentration-to-dose ratios, and elderly patients (>65 years) show 27% higher ratios compared to younger individuals, necessitating individualized dosing 9
- For insomnia: Low doses (7.5-15 mg/day) are used, though evidence shows benefits are primarily short-term (6 weeks) 5
Pediatric Warning
A 2023 case report documented severe periodic limb movement disorder in a 9-year-old taking mirtazapine for insomnia, which resolved after discontinuation 10. This highlights the need for caution when considering off-label pediatric use.
Evidence Quality
Most off-label uses are supported primarily by case reports and open-label studies rather than randomized controlled trials 3. The strongest evidence exists for MDD and, more recently, for short-term insomnia management 5. Clinicians should weigh the limited evidence base against potential benefits when prescribing for off-label indications.